Indicators of hypercoagulability and recurrent venous thromboembolism in the elderly: rethinking age and thrombophilia.
作者信息
Middeldorp Saskia
机构信息
Department of Internal Medicine, Radboud university medical center, Nijmegen, The Netherlands.
出版信息
Res Pract Thromb Haemost. 2023 Feb 15;7(1):100056. doi: 10.1016/j.rpth.2023.100056. eCollection 2023 Jan.
Abstract
摘要
相似文献
1
Indicators of hypercoagulability and recurrent venous thromboembolism in the elderly: rethinking age and thrombophilia.老年人高凝状态及复发性静脉血栓栓塞的指标：对年龄与易栓症的重新思考
Res Pract Thromb Haemost. 2023 Feb 15;7(1):100056. doi: 10.1016/j.rpth.2023.100056. eCollection 2023 Jan.
2
Laboratory thrombophilias and venous thromboembolism.实验室检测的易栓症与静脉血栓栓塞症
Vasc Med. 2002 May;7(2):93-102. doi: 10.1191/1358863x02vm426ra.
3
Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?因子 V 莱顿和凝血酶原 G20210A 突变是否可预测老年患者复发性静脉血栓栓塞症？
Am J Med. 2017 Oct;130(10):1220.e17-1220.e22. doi: 10.1016/j.amjmed.2017.05.026. Epub 2017 Jun 9.
4
Should patients with venous thromboembolism be screened for thrombophilia?静脉血栓栓塞症患者是否应该接受易栓症筛查？
Am J Med. 2008 Jun;121(6):458-63. doi: 10.1016/j.amjmed.2007.10.042.
5
Idiopathic venous thromboembolism and thrombophilia.特发性静脉血栓栓塞症与易栓症
J Med Life. 2011 Jan-Mar;4(1):57-62. Epub 2011 Feb 25.
6
Chloroquine reduces hypercoagulability in pancreatic cancer through inhibition of neutrophil extracellular traps.氯喹通过抑制中性粒细胞胞外诱捕网减少胰腺癌的高凝状态。
BMC Cancer. 2018 Jun 22;18(1):678. doi: 10.1186/s12885-018-4584-2.
7
Thrombophilia in pregnancy.妊娠期血栓形成倾向
Ann Acad Med Singap. 2002 May;31(3):328-34.
8
Thrombophilia and hypercoagulability.血栓形成倾向和血液高凝状态。
Med Princ Pract. 2009;18(6):429-40. doi: 10.1159/000235891. Epub 2009 Sep 30.
9
Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review.遗传性易栓症携带者静脉血栓栓塞症一级和二级预防的知识进展：一项叙述性综述
Semin Thromb Hemost. 2022 Nov;48(8):937-948. doi: 10.1055/s-0042-1753527. Epub 2022 Sep 2.
10
Hereditary thrombophilia and venous thromboembolism: critical evaluation of the clinical implications of screening.遗传性血栓形成倾向与静脉血栓栓塞症：筛查临床意义的批判性评估
Eur J Vasc Endovasc Surg. 2007 Oct;34(4):483-8. doi: 10.1016/j.ejvs.2007.04.023. Epub 2007 Jun 27.
引用本文的文献
1
Exploring the Therapeutic Potential of FSGTC for Osteoarthritis: A Comprehensive Study Combining Nested Case Analysis, Network Pharmacology, and Experimental Validation.探索FSGTC对骨关节炎的治疗潜力：一项结合巢式病例分析、网络药理学和实验验证的综合研究
Drug Des Devel Ther. 2025 Jun 17;19:5123-5141. doi: 10.2147/DDDT.S517935. eCollection 2025.
2
Clinical evaluation of hypercoagulability in advanced malignant tumors using thromboelastography and conventional coagulation tests.使用血栓弹力图和传统凝血试验对晚期恶性肿瘤高凝状态的临床评估
Medicine (Baltimore). 2025 Feb 7;104(6):e41465. doi: 10.1097/MD.0000000000041465.
本文引用的文献
1
Procoagulant factor levels and risk of venous thrombosis in the elderly.老年人促凝血因子水平与静脉血栓形成风险
J Thromb Haemost. 2021 Jan;19(1):186-193. doi: 10.1111/jth.15127. Epub 2020 Dec 22.
2
Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?因子 V 莱顿和凝血酶原 G20210A 突变是否可预测老年患者复发性静脉血栓栓塞症？
Am J Med. 2017 Oct;130(10):1220.e17-1220.e22. doi: 10.1016/j.amjmed.2017.05.026. Epub 2017 Jun 9.
3
Inherited thrombophilia: a double-edged sword.遗传性血栓形成倾向：一把双刃剑。
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):1-9. doi: 10.1182/asheducation-2016.1.1.
4
Mechanistic view of risk factors for venous thromboembolism.静脉血栓栓塞症风险因素的机制观点。
Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):563-8. doi: 10.1161/ATVBAHA.111.242818.
5
Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.凝血因子V莱顿突变和凝血酶原G20210A突变在成年静脉血栓栓塞症患者及其携带突变的家庭成员中的预测价值：一项系统评价
JAMA. 2009 Jun 17;301(23):2472-85. doi: 10.1001/jama.2009.853.
6
Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial.B族维生素降低同型半胱氨酸水平与深静脉血栓形成和肺栓塞的二级预防：一项随机、安慰剂对照、双盲试验。
Blood. 2007 Jan 1;109(1):139-44. doi: 10.1182/blood-2006-04-014654. Epub 2006 Sep 7.
7
Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.同型半胱氨酸、亚甲基四氢叶酸还原酶与静脉血栓形成风险：已发表的流行病学研究的荟萃分析
J Thromb Haemost. 2005 Feb;3(2):292-9. doi: 10.1111/j.1538-7836.2005.01141.x.
8
Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis.家族中FVIII:C水平升高与静脉和动脉血栓形成风险增加相关。
J Thromb Haemost. 2005 Jan;3(1):79-84. doi: 10.1111/j.1538-7836.2004.01033.x.
9
The genetics of haemostasis: a twin study.止血的遗传学：一项双胞胎研究。
Lancet. 2001 Jan 13;357(9250):101-5. doi: 10.1016/S0140-6736(00)03541-8.
Zotero 插件